CN Stock MarketDetailed Quotes
603566 Pulike Biological Engineering,Inc.
- 13.40
- +0.23+1.75%
Market Closed Nov 29 15:00 CST
4.64BMarket Cap45.58P/E (TTM)
13.58High13.01Low65.73KlotVolume13.10Open13.17Pre Close88.26MTurnover1.90%Turnover Ratio26.59P/E (Static)346.06MShares24.6052wk High1.76P/B4.64BFloat Cap10.8052wk Low14.49Limit Up346.06MShs Float40.48Historical High11.85Limit Down4.33%Amplitude8.36Historical Low0.40Dividend TTM13.43Avg Price28.19KlotAsk2.99%Div YieldTTM100Lot Size36.31KlotBid
Pulike Biological Engineering,Inc. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -17.34%787.11M | -22.22%484.21M | -27.30%242.45M | 23.69%1.31B | 36.53%952.23M | 43.98%622.52M | 80.77%333.5M | 4.97%1.06B | -6.34%697.46M | -7.03%432.37M |
| Refunds of taxes and levies | -59.43%2.34M | -98.84%66.55K | ---- | 48.77%5.99M | 11.78%5.76M | 190.76%5.76M | -99.94%661.42 | 47.21%4.03M | 10,283.13%5.15M | 3,891.67%1.98M |
| Cash received relating to other operating activities | -24.50%40.52M | 45.22%42.9M | -26.53%17.18M | 36.64%72.97M | -24.14%53.67M | -50.89%29.54M | 22.41%23.38M | -27.16%53.4M | 18.56%70.75M | 93.50%60.15M |
| Cash inflows from operating activities | -17.96%829.97M | -19.86%527.18M | -27.25%259.63M | 24.40%1.39B | 30.81%1.01B | 33.03%657.82M | 74.32%356.89M | 2.90%1.11B | -3.85%773.36M | -0.34%494.51M |
| Goods services cash paid | -23.76%228.39M | -34.56%147.42M | -43.77%77.24M | 34.72%368.65M | 62.54%299.59M | 70.35%225.29M | 90.66%137.36M | -16.14%273.64M | -32.41%184.32M | -33.57%132.25M |
| Staff behalf paid | -3.43%178.08M | -3.32%129.78M | -2.71%81.68M | 5.93%239.44M | 3.46%184.41M | 5.18%134.24M | 5.33%83.96M | 4.60%226.03M | 8.47%178.24M | 8.02%127.63M |
| All taxes paid | -34.04%56.6M | -44.03%38.18M | -46.44%19.16M | 63.35%107.93M | 94.20%85.8M | 145.25%68.22M | 147.67%35.78M | -20.06%66.08M | -38.92%44.18M | -49.61%27.82M |
| Cash paid relating to other operating activities | -4.77%240.53M | 5.09%163.65M | 27.09%85.94M | 20.98%387.67M | 29.57%252.57M | 24.85%155.72M | 43.79%67.62M | 30.51%320.46M | 19.42%194.93M | 24.41%124.72M |
| Cash outflows from operating activities | -14.44%703.6M | -17.90%479.03M | -18.69%264.02M | 24.54%1.1B | 36.68%822.37M | 41.47%583.46M | 52.28%324.72M | 1.79%886.2M | -10.55%601.67M | -12.75%412.42M |
| Net cash flows from operating activities | -33.24%126.37M | -35.25%48.15M | -113.66%-4.39M | 23.83%282.78M | 10.25%189.29M | -9.41%74.37M | 478.44%32.17M | 7.44%228.36M | 30.29%171.69M | 249.08%82.09M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -31.87%1.3B | -39.74%921.53M | -67.03%285.53M | 1,149.08%2.41B | 1,694.45%1.91B | 1,410.18%1.53B | 799.35%866M | -71.79%193.02M | -84.12%106.27M | -81.73%101.27M |
| Cash received from returns on investments | -44.18%12.06M | -2.81%9.61M | 114.92%13.45M | 2.55%26.43M | -13.70%21.6M | -59.81%9.88M | -69.05%6.26M | 208.19%25.77M | 203.21%25.03M | 317.72%24.59M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 32.68%238.26K | -93.76%11.2K | -88.51%970 | -4.20%428.95K | 50.56%179.57K | 52.44%179.47K | -92.80%8.44K | -58.18%447.75K | 0.51%119.27K | 22.60%117.73K |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.5M | ---- | ---- |
| Cash inflows from investing activities | -32.00%1.31B | -39.51%931.15M | -65.72%298.98M | 1,004.38%2.44B | 1,367.59%1.93B | 1,121.96%1.54B | 647.94%872.26M | -68.18%220.75M | -80.61%131.42M | -77.51%125.98M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -66.83%84.35M | -64.69%72.75M | -50.44%61.15M | -14.61%304.98M | 17.37%254.28M | 59.28%206.03M | 93.02%123.4M | 12.48%357.16M | 37.01%216.65M | 51.07%129.35M |
| Cash paid to acquire investments | -27.17%1.26B | -48.06%697.52M | -55.05%333.52M | 157.87%2.11B | 4,911.79%1.73B | 31,971.64%1.34B | 37,000.00%742M | 61.60%818.78M | -93.05%34.58M | -99.06%4.19M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --23.14M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -32.25%1.35B | -50.27%770.28M | -54.39%394.67M | 107.45%2.44B | 691.08%1.99B | 1,059.99%1.55B | 1,212.59%865.4M | 42.67%1.18B | -61.67%251.23M | -74.94%133.54M |
| Net cash flows from investing activities | 40.30%-35.05M | 1,768.82%160.87M | -1,493.15%-95.7M | 99.83%-1.66M | 50.99%-58.71M | -27.50%-9.64M | -86.45%6.87M | -631.92%-955.19M | -638.89%-119.81M | -127.56%-7.56M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | -99.82%1.6M | --1.6M | --1.1M | --892.42M | --892.42M | ---- |
| Cash from borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --37M | --37.2M | --37M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | --48.91M | --48.91M | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | ---- | ---- | ---- | ---- | -94.57%50.51M | 36.53%50.51M | -97.03%1.1M | --929.42M | --929.62M | --37M |
| Borrowing repayment | ---- | ---- | ---- | -76.67%7M | -76.82%7M | --7M | --7M | --30M | --30.2M | ---- |
| Dividend interest payment | 13.75%137.85M | 13.75%137.85M | ---- | 253.50%225M | 84.76%121.18M | 85.51%121.18M | -4.60%58.43K | -59.54%63.65M | -58.31%65.59M | -58.48%65.32M |
| Cash payments relating to other financing activities | 115.28%52.83M | 5,692.39%33.08M | 2,948.63%17.77M | 198.01%9.03M | 2,357.05%24.54M | 185.53%571.05K | --582.84K | 1,094.99%3.03M | 864.92%998.8K | 93.22%200K |
| Cash outflows from financing activities | 24.85%190.68M | 32.75%170.92M | 132.53%17.77M | 149.31%241.03M | 57.79%152.72M | 96.50%128.75M | 12,375.54%7.64M | -38.65%96.68M | -38.52%96.79M | -58.38%65.52M |
| Net cash flows from financing activities | -86.56%-190.68M | -118.47%-170.92M | -171.64%-17.77M | -128.94%-241.03M | -112.27%-102.21M | -174.29%-78.24M | -117.71%-6.54M | 628.48%832.74M | 629.04%832.83M | 81.88%-28.52M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -729.02%-16.72K | 9,417.01%146.8K | 135.63%37.21K | -8.62%311.47K | -98.13%2.66K | -102.16%-1.58K | -334.10%-104.43K | 257.85%340.84K | 225.62%141.84K | 3,058.88%73.05K |
| Net increase in cash and cash equivalents | -450.22%-99.38M | 383.09%38.25M | -463.73%-117.82M | -61.98%40.4M | -96.79%28.37M | -129.32%-13.51M | -59.05%32.39M | 240.24%106.25M | 26,324.14%884.86M | 143.28%46.08M |
| Add:Begin period cash and cash equivalents | 14.89%311.77M | 14.89%311.77M | 14.83%311.77M | 64.34%271.37M | 64.34%271.37M | 64.96%271.37M | 65.04%271.51M | -31.27%165.13M | -31.27%165.13M | -31.53%164.51M |
| End period cash equivalent | -29.14%212.4M | 35.74%350.02M | -36.18%193.95M | 14.89%311.77M | -71.45%299.75M | 22.45%257.86M | 24.75%303.9M | 64.96%271.37M | 343.23%1.05B | 57.39%210.59M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data